Carmel Biosciences Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CARMEL BIOSCIENCES, and what generic and branded alternatives to CARMEL BIOSCIENCES drugs are available?
CARMEL BIOSCIENCES has one approved drug.
Summary for Carmel Biosciences
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Carmel Biosciences
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Carmel Biosciences | PREXXARTAN | valsartan | SOLUTION;ORAL | 209139-001 | Dec 19, 2017 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Carmel Biosciences | PREXXARTAN | valsartan | SOLUTION;ORAL | 209139-002 | Dec 19, 2017 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
